Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-01-28, Stock:LLY, The news for the past five days is as follows:
2021-01-21: NEWS1: Coronavirus update: Biden signs more COVID-19 orders; Pfizer wants to expand sales to states.NEWS2: Eli Lilly's Antibody Reduces COVID-19 Risk by 80% in Nursing Homes.NEWS3: Lilly's neutralizing antibody bamlanivimab (LY-CoV555) prevented COVID-19 at nursing homes in the BLAZE-2 trial, reducing risk by up to 80 per cent for residents.NEWS4: Jim Cramer on Amazon, Eli Lilly, FuelCell, Vaccines, Stock Market Thursday.NEWS5: LIVE: Jim Cramer on Amazon, Eli Lilly, FuelCell, FAANG, Stock Market Thursday.NEWS6: Eli Lilly Says Covid-19 Treatment Reduces Risk for Nursing Home Residents.NEWS7: Eli Lilly Says Its Antibody Prevented Covid-19 in Nursing Home Residents.NEWS8: Lilly says antibody drug cuts COVID-19 risk for nursing home residents.NEWS9: Lilly's neutralizing antibody bamlanivimab (LY-CoV555) prevented COVID-19 at nursing homes in the BLAZE-2 trial, reducing risk by up to 80 percent for residents.
2021-01-22: NEWS1: Lilly's (LLY) Bamlanivimab Lowers COVID-19 Risk in Nursing Homes.NEWS2: Lilly Completes Acquisition of Prevail Therapeutics.NEWS3: Pharma Stock Roundup: FDA Nod to MRK, AZN, JNJ, GSK Drugs, LLY's New Antibody Deal.NEWS4: The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa.
2021-01-25: NEWS1: Will Eli Lilly (LLY) Beat Estimates This Earnings Season?.
2021-01-26: NEWS1: Coronavirus update: J&J to release vaccine data next week; strain from Brazil confirmed in US.NEWS2: New data show treatment with etesevimab (JS016) and bamlanivimab together reduced risk of COVID-19 hospitalizations and death by 70 percent.NEWS3: Eli Lilly and Regeneron Report More Positive Data on Covid-19 Antibody Cocktails.NEWS4: Regeneron's (REGN) Performance Strong in 2020: What Lies Ahead?.NEWS5: Lilly says late-stage study showed combo therapy can reduce deaths and hospitalizations in COVID-19 patients.NEWS6: General Electric, Johnson & Johnson - Tuesday's Premarket Movers.NEWS7: The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market.NEWS8: Eli Lilly Shares Gain After Positive Data From Late-Stage Covid Treatment Trial.NEWS9: New data show treatment with Lilly's neutralizing antibodies bamlanivimab (LY-CoV555) and etesevimab (LY-CoV016) together reduced risk of COVID-19 hospitalizations and death  by 70 percent.
2021-01-27: NEWS1: Lilly's (LLY) Bamlanivimab Combo Lowers COVID-19 Hospitalization.NEWS2: Vir Will Test Its Covid-19 Antibody With Eli Lilly’s, Sending Shares Up Again.NEWS3: The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement.NEWS4: Lilly, Vir Biotechnology and GSK announce first patient dosed in expanded BLAZE-4 trial evaluating bamlanivimab (LY-CoV555) with VIR-7831 (GSK4182136) for COVID-19.NEWS5: Eli Lilly’s Antibody Therapy Cuts Covid-19 Hospitalization By 70%.NEWS6: Eli Lilly, Regeneron's COVID-19 treatments may be weaker against South Africa variant-study.

Answer: Rise